Authors Gerald Shadel and Melissa Johnson (IMAGE)

Salk Institute

Authors Gerald Shadel and Melissa Johnson

Caption

Gerald Shadel (left) and Melissa Johnson (right) discovered a key switch that links chronic interferon II exposure to immunosuppression in mice, exposing a new potential target for therapies to address immunotherapy-resistant cancer.

Credit

Salk Institute

Usage Restrictions

With credit and related coverage

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.